Mechanism of action
Antiplatelet agent.
P2Y12 receptor antagonists (ADP receptor inhibitor) and hence inhibiting platelet activation and aggregation with rapid onset and offset
Indications and dose
Side-effects
Bleeding
Hypersensitivity (allergy, SJS, TEN, Erythema multidorme)
Pharmacokinetics
Onset of action:Within 2 minutes
Brand: Kengreal, Kengrexal
Half-life of elimination: 3 minutes
Excretion: 58% Urine and 35% Feces
Directions for administration: IV administration
Medicinal forms
Intravenous only
References
- https://go.drugbank.com/drugs/DB06441
- https://next.amboss.com/us/article/Um0bUg?q=clopidogrel#Zb288dda860ff65493b01ea10fbf1e10c
- https://online.epocrates.com/drugs/722505/Kengreal/Adverse-Reactions
